Dynamic changes of Plasmodium vivax population structure in South Korea

2016 ◽  
Vol 45 ◽  
pp. 90-94 ◽  
Author(s):  
Jung-Mi Kang ◽  
Jinyoung Lee ◽  
Pyo-Yun Cho ◽  
Tae Im Kim ◽  
Woon-Mok Sohn ◽  
...  
2010 ◽  
Vol 9 (1) ◽  
Author(s):  
Peter Van den Eede ◽  
Gert Van der Auwera ◽  
Christopher Delgado ◽  
Tine Huyse ◽  
Veronica E Soto-Calle ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (12) ◽  
pp. e82553 ◽  
Author(s):  
Noor Rain Abdullah ◽  
Bridget E. Barber ◽  
Timothy William ◽  
Nor Azrina Norahmad ◽  
Umi Rubiah Satsu ◽  
...  

2015 ◽  
Vol 91 (11) ◽  
pp. fiv127 ◽  
Author(s):  
Jeonghwan Jang ◽  
Doris Y. W. Di ◽  
Dukki Han ◽  
Tatsuya Unno ◽  
Jeom-Ho Lee ◽  
...  

2021 ◽  
Vol 6 (2) ◽  
pp. e004292
Author(s):  
Jung Ho Kim ◽  
Jiyeon Suh ◽  
Woon Ji Lee ◽  
Heun Choi ◽  
Jong-Dae Kim ◽  
...  

BackgroundRapid diagnostic tests (RDTs) are widely used for diagnosing Plasmodium vivax malaria, especially in resource-limited countries. However, the impact of RDTs on P. vivax malaria incidence and national medical costs has not been evaluated. We assessed the impact of RDT implementation on P. vivax malaria incidence and overall medical expenditures in South Korea and performed a cost–benefit analysis from the payer’s perspective.MethodsWe developed a dynamic compartmental model for P. vivax malaria transmission in South Korea using delay differential equations. Long latency and seasonality were incorporated into the model, which was calibrated to civilian malaria incidences during 2014–2018. We then estimated averted malaria cases and total medical costs from two diagnostic scenarios: microscopy only and both microscopy and RDTs. Medical costs were extracted based on data from a hospital in an at-risk area for P. vivax malaria and were validated using Health Insurance Review and Assessment Service data. We conducted a cost–benefit analysis of RDTs using the incremental benefit:cost ratio (IBCR) considering only medical costs and performed a probabilistic sensitivity analysis to reflect the uncertainties of model parameters, costs and benefits.ResultsThe results showed that 55.3% of new P. vivax malaria cases were averted, and $696 214 in medical costs was saved over 10 years after RDT introduction. The estimated IBCR was 2.5, indicating that RDT implementation was beneficial, compared with microscopy alone. The IBCR was sensitive to the diagnosis time reduction, infectious period and short latency period, and provided beneficial results in a benefit over $10.6 or RDT cost under $39.7.ConclusionsThe model simulation suggested that RDTs could significantly reduce P. vivax malaria incidence and medical costs. Moreover, cost–benefit analysis demonstrated that the introduction of RDTs was beneficial over microscopy alone. These results support the need for widespread adoption of RDTs.


2012 ◽  
Vol 11 (1) ◽  
pp. 68 ◽  
Author(s):  
Stella M Chenet ◽  
Lorena L Tapia ◽  
Ananias A Escalante ◽  
Salomon Durand ◽  
Carmen Lucas ◽  
...  

2009 ◽  
Vol 15 (1) ◽  
pp. 27-33
Author(s):  
Moritoshi Iwagami ◽  
Shigeyuki Kano ◽  
Ichiro Itoda ◽  
Seung-Young Hwang ◽  
Weon-Gyu Kho

Crop Science ◽  
2013 ◽  
Vol 53 (4) ◽  
pp. 1537-1545 ◽  
Author(s):  
Sanjaya Gyawali ◽  
Dwayne D. Hegedus ◽  
Isobel A. P. Parkin ◽  
Jenny Poon ◽  
Erin Higgins ◽  
...  

2019 ◽  
Vol 101 (4) ◽  
pp. 803-805
Author(s):  
Jae Hyoung Im ◽  
Moon-Hyun Chung ◽  
Areum Durey ◽  
Hea Yoon Kwon ◽  
Jin-Soo Lee ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Tian-Qi Shi ◽  
Hai-Mo Shen ◽  
Shen-Bo Chen ◽  
Kokouvi Kassegne ◽  
Yan-Bing Cui ◽  
...  

Malaria incidence has declined dramatically over the past decade and China was certified malaria-free in 2021. However, the presence of malaria in border areas and the importation of cases of malaria parasites are major challenges for the consolidation of the achievements made by China. Plasmodium vivax Duffy binding protein (PvDBP) performs a significant role in erythrocyte invasion, and is considered a promising P. vivax vaccine. However, the highly polymorphic region of PvDBP (PvDBP-II) impedes the development of blood-stage vaccine against P. vivax. In this study, we investigated the genetic diversity and natural selection of PvDBP-II among 124 P. vivax isolates collected from the China-Myanmar border (CMB) in Yunnan Province, China, during 2009–2011. To compare genetic diversity, natural selection, and population structure with CMB isolates, 85 pvdbp-II sequences of eastern Myanmar isolates were obtained from GenBank. In addition, global sequences of pvdbp-II were retrieved from GenBank to establish genetic differentiation relationships and networks with the CMB isolates. In total, 22 single nucleotide polymorphisms reflected in 20 non-synonymous and two synonymous mutations were identified. The overall nucleotide diversity of PvDBP-II from the 124 CMB isolates was 0.0059 with 21 haplotypes identified (Hd = 0.91). The high ratio of non-synonymous to synonymous mutations suggests that PvDBP-II had evolved under positive selection. Population structure analysis of the CMB and eastern Myanmar isolates were optimally grouped into five sub-populations (K = 5). Polymorphisms of PvDBP-II display that CMB isolates were genetically diverse. Mutation, recombination, and positive selection promote polymorphism of PvDBP-II of P. vivax population. Although low-level genetic differentiation in eastern Myanmar was identified along with the more effective malaria control measures, the complexity of population structure in malaria parasites has maintained. In conclusion, findings from this study advance knowledge of the understanding of the dynamic of P. vivax population, which will contribute to guiding the rational design of a PvDBP-II based vaccine.


Sign in / Sign up

Export Citation Format

Share Document